An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma

Area of Science:

• Biochemistry
• Immunology
• Clinical Diagnostics

Background:

• Native C-reactive protein (nCRP) is a non-specific inflammation marker, often acting as a bystander in chronic diseases.
• Evidence suggests monomeric C-reactive protein (mCRP) is the active form at inflammatory sites, potentially offering higher specificity.
• Quantifying mCRP in clinical samples has been challenging due to a lack of suitable assays.

Purpose of the Study:

• To develop a reliable sandwich ELISA assay for quantifying plasma mCRP.
• To assess if mCRP is a more specific and causally relevant disease marker than nCRP.
• To provide a tool for evaluating the clinical utility of mCRP.

Main Methods:

• Development of a sandwich ELISA assay using commercially available reagents.
• Validation of the assay for reproducibility and conformation specificity.
• Determination of the assay's detection limit.

Main Results:

• A reproducible and highly conformation-specific sandwich ELISA for plasma mCRP was successfully developed.
• The assay demonstrates a reliable detection limit of 1 ng/mL.
• mCRP was identified as a potentially superior marker compared to nCRP in certain autoimmune skin disorders.

Conclusions:

• The developed ELISA assay enables accurate quantification of plasma mCRP.
• mCRP shows promise as a more specific biomarker for inflammation and pathogenesis than nCRP.
• This assay is a valuable tool for future clinical studies on mCRP's significance.